Hydroxycarbamide for Acute Myeloid Leukaemia (AML)

What's in this booklet? 

Hydroxycarbamide (also sometimes called hydroxyurea) is a chemotherapy drug which is used in patients with acute myeloid leukaemia (AML), chronic myeloid leukaemia (CML) and myeloproliferative neoplasms (MPNs) to reduce the high numbers of certain cell types in the blood. In acute leukaemia it is mainly used to control the numbers of immature cells called ‘blasts’ in the blood.

This patient information booklet is for patients, their family members, friends and carers who would like to know more about this drug. So, we will try and answer some questions like what is hydroxycarbamide, who receives it, how it is administered, what are the side effects and what other possible treatments are out there if hydroxycarbamide does not work.

This hardcopy version of our booklet can be ordered free of charge to UK addresses. 

Digital downloads

To access an instant download of our Hydroxycarbamide for Acute myeloid leukaemia information booklet, please click here (opens as a PDF file). 

All our information is available free of charge to people affected by leukaemia and associated conditions. It costs us approximately £3 to provide one booklet. Please consider adding a donation to your order if you can.